Li Lianda
   HOME

TheInfoList



OR:

Li Lianda (; 24 July 1934 – 18 October 2018) was a Chinese
pharmacologist Pharmacology is the science of drugs and medications, including a substance's origin, composition, pharmacokinetics, pharmacodynamics, therapeutic use, and toxicology. More specifically, it is the study of the interactions that occur between ...
and
paediatrician Pediatrics (American English) also spelled paediatrics (British English), is the branch of medicine that involves the medical care of infants, children, adolescents, and young adults. In the United Kingdom, pediatrics covers many of their yout ...
with the China Academy of Chinese Medical Sciences. He was an academician of the
Chinese Academy of Engineering The Chinese Academy of Engineering (CAE, ) is the national academy of the People's Republic of China for engineering. It was established in 1994 and is an institution of the State Council of China. The CAE and the Chinese Academy of Sciences a ...
and served as Dean of the School of Pharmacy of
Zhejiang University Zhejiang University (ZJU) is a public university, public research university in Hangzhou, Zhejiang, China. It is affiliated with the Ministry of Education (China), Ministry of Education. The university is part of Project 211, Project 985, and D ...
.


Biography

Li was born on 24 July 1934 in
Shenyang Shenyang,; ; Mandarin pronunciation: ; formerly known as Fengtian formerly known by its Manchu language, Manchu name Mukden, is a sub-provincial city in China and the list of capitals in China#Province capitals, provincial capital of Liaonin ...
,
Liaoning ) , image_skyline = , image_alt = , image_caption = Clockwise: Mukden Palace in Shenyang, Xinghai Square in Dalian, Dalian coast, Yalu River at Dandong , image_map = Liaoning in China (+all claims hatched).svg , ...
, China. After graduating from
Beijing Medical College Peking University Health Science Center is the medical school of Peking University, which has 14 affiliated hospitals in Beijing, China. It was formerly the independent Beijing Medical University between 1952 and 2000. History It was first esta ...
in 1956, he worked at Xiyuan Hospital, which is affiliated with the China Academy of Chinese Medical Sciences (CACMS), and practiced as a
paediatrician Pediatrics (American English) also spelled paediatrics (British English), is the branch of medicine that involves the medical care of infants, children, adolescents, and young adults. In the United Kingdom, pediatrics covers many of their yout ...
for 18 years. In 1974, Li began researching on the
pharmacology Pharmacology is the science of drugs and medications, including a substance's origin, composition, pharmacokinetics, pharmacodynamics, therapeutic use, and toxicology. More specifically, it is the study of the interactions that occur betwee ...
of
traditional Chinese medicine Traditional Chinese medicine (TCM) is an alternative medicine, alternative medical practice drawn from traditional medicine in China. A large share of its claims are pseudoscientific, with the majority of treatments having no robust evidence ...
. He later served as Director of Basic Medical Research at Xiyuan Hospital, and chief scientist at the CACMS. His research on the scientific basis of the traditional Chinese medical concept of blood stasis won the National Science and Technology Progress Award, First Class. He also pioneered a new procedure to treat
coronary artery disease Coronary artery disease (CAD), also called coronary heart disease (CHD), or ischemic heart disease (IHD), is a type of cardiovascular disease, heart disease involving Ischemia, the reduction of blood flow to the cardiac muscle due to a build-up ...
using a combination of Chinese medicine and
stem cells In multicellular organisms, stem cells are undifferentiated or partially differentiated cells that can change into various types of cells and proliferate indefinitely to produce more of the same stem cell. They are the earliest type of cell ...
, which won the China Medical Society Science and Technology Award, First Class. Li was elected an academician of the
Chinese Academy of Engineering The Chinese Academy of Engineering (CAE, ) is the national academy of the People's Republic of China for engineering. It was established in 1994 and is an institution of the State Council of China. The CAE and the Chinese Academy of Sciences a ...
in 2003. From 2004 to 2009, he served as Dean of the School of Pharmacy of
Zhejiang University Zhejiang University (ZJU) is a public university, public research university in Hangzhou, Zhejiang, China. It is affiliated with the Ministry of Education (China), Ministry of Education. The university is part of Project 211, Project 985, and D ...
in
Hangzhou Hangzhou, , Standard Mandarin pronunciation: ; formerly romanized as Hangchow is a sub-provincial city in East China and the capital of Zhejiang province. With a population of 13 million, the municipality comprises ten districts, two counti ...
. On 18 October 2018, Li died in Beijing at the age of 84.


Controversies

In 2008, Li was implicated in an academic scandal at Zhejiang University. A
postdoctoral researcher A postdoctoral fellow, postdoctoral researcher, or simply postdoc, is a person professionally conducting research after the completion of their doctoral studies (typically a PhD). Postdocs most commonly, but not always, have a temporary acade ...
at the School of Pharmacy, He Haibo (), was found to have published 14 articles in international journals that used falsified or plagiarized data, and Li was listed as a co-author. He Haibo admitted wrongdoing and said that he had submitted the articles using Li's name without his permission. An investigation by the university cleared Li of wrongdoing, and He Haibo, by then an associate professor, was fired. Li took personal responsibility for his lax supervision of He, although he said that his busy schedule which required him to spend most of his time in Beijing and his lack of English proficiency impeded his ability to scrutinize He's articles that were written in English. In 2009, Li was involved in a dispute with the Chinese pharmaceutical company
Tasly Tasly ( zh, s=天士力控股集团, p=Tiānshìlì Kònggǔ Jítuán) is a Chinese pharmaceutical company based in the city of Tianjin.
when he claimed that a key product made by Tasly was unsafe. Tasly sued Li in 2013, alleging that Li's claim was baseless and was motivated by his financial and employment relations with Guangzhou Pharmaceutical, a direct competitor of Tasly. In September 2014, the
Tianjin Tianjin is a direct-administered municipality in North China, northern China on the shore of the Bohai Sea. It is one of the National Central City, nine national central cities, with a total population of 13,866,009 inhabitants at the time of the ...
High People's Court ruled in favour of Tasly and ordered Li to issue an apology and pay Tasly 300,000 yuan in compensation.


References

{{DEFAULTSORT:Li, Lianda 1934 births 2018 deaths 20th-century Chinese physicians 21st-century Chinese physicians Chinese paediatricians Chinese pharmacologists Educators from Liaoning Members of the Chinese Academy of Engineering Peking University alumni People from Shenyang Physicians from Liaoning Scientists from Liaoning Academic staff of Zhejiang University